Want to develop vaccines in Africa? Then invest in expertise and infrastructure

By Bryan Trevor Sewell, Senior Scholar (former Director of the Electron Microscope Unit and Professor in the Department of integrated Biomedical Sciences), University of Cape Town
Jeremy David Woodward, Chief Scientific Officer, University of Cape Town
Lauren B. Arendse, FLAIR Fellow, Drug Discovery and Development (H3D) Centre, University of Cape Town
Thandeka Moyo-Gwete, Senior Medical Scientist, National Institute for Communicable Diseases
Wolf-Dieter Schubert, Professor of Biochemistry, University of Pretoria

Making vaccines in South Africa by building on the foundation that’s been laid is possible. But only if substantial and sustained investment in human resources and infrastructure becomes a reality.

Read complete article

~	How visas for social care workers may be exacerbating exploitation in the sector

~	Why the British Columbia Conservation Officer Service should be designated as a provincial police service

~	Detaining migrants in prisons violates human rights and risks abuses

~	Granting legal ‘personhood’ to nature is a growing movement – can it stem biodiversity loss?

~	Friday essay: Project 2025, the policy substance behind Trump’s showmanship, reveals a radical plan to reshape the world

~	Longer-lasting ozone holes over Antarctica expose seal pups and penguin chicks to much more UV

~	New rock art discoveries in Eastern Sudan tell a tale of ancient cattle, the ‘green Sahara’ and climate catastrophe

~	Will checking character references really help you find the best candidate for a job?

~	China’s money only goes so far – Kokoda shows why history binds PNG and Australia in a far deeper way

~	We spoke to young people about sexual consent. They understand the concept, but don’t always ask in the moment